跳至主要内容
临床试验/NCT04686552
NCT04686552已完成不适用

Effects of Cinnamon Spice on Postprandial Glucose and Insulin in Normal Weight and Obese Individuals With Pre-Diabetes: A Pilot Study

University of California, Los Angeles1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2018年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
1
主要终点
insulin

研究概览

简要总结

The objective of the proposed study is to investigate the effect of cinnamon on the postprandial glycemic response to a high glycemic index meal in normal and overweight/obese prediabetic subjects

详细描述

A randomized crossover study design will be carried out in accordance with the guidelines of the Human Subjects Protection Committee of the University of California, Los Angeles. All subjects will give written informed consent before the study begins. There will be two groups of participants (normal and overweight/obese). Each participant will consume oatmeal prepared with 1 cup of 2% milk served with or without 6 g of ground cinnamon in random sequence. At each meal consumption blood will be collected to measure postprandial glucose and insulin at 0, 30, 60, 90, 120, 150 and 180 minutes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Healthy human adults age 20-50 years' old
  • •Typically consume low fiber/polyphenol diet (beige diet)
  • •normal weight individuals with a BMI of
  • •to 24.9 kg/ m2 with fasting serum glucose <100 mg/dL
  • •overweight/obese individuals with a BMI of 25 to 35 kg/m2 and fasting serum glucose ≥100 mg/dL and <126 mg/dL or HbA1c >5.7% and < 6.5%.
  • •Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent.

排除标准

  • •Any subject with a screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator.
  • •Any subject currently taking blood thinning medications such as Warfarin or Coumadin
  • •Any history of gastrointestinal disease or surgery except for appendectomy or cholecystectomy.
  • •Eating a high fiber/polyphenol diet or taking any medication or dietary supplement which interfere with the absorption of polyphenols.
  • •History of gastrointestinal surgery, diabetes mellitus, or other serious medical condition, such as chronic hepatic or renal disease, bleeding disorder, congestive heart disease, chronic diarrhea disorders, myocardial infarction, coronary artery bypass graft, angioplasty within 6 months prior to screening, current diagnosis of uncontrolled hypertension (defined as systolic BP >160mmHg, diastolic BP >95mmHg), active or chronic gastrointestinal disorders, bulimia, anorexia, laxative abuse, or endocrine diseases (except thyroid disease requiring medication) as indicated by medical history.
  • •Pregnant or breastfeeding
  • •Currently uses tobacco products.
  • •Currently has an alcohol intake > 20 g ⁄ day;
  • •Currently has a coffee intake > 3 cups ⁄ day;
  • •Allergy or sensitivity to cinnamon. Subjects will be excluded if there is a prior history of such sensitivity. Since these foods are commonly eaten and allergies are rare, subjects should be aware of this sensitivity prior to entering the study. To determine this, a positive history of cinnamon ingestion without incident will be requested. In addition, any subject with a history of allergy or anaphylaxis of any kind will be excluded
  • •Is lactose intolerant
  • •Is unable or unwilling to comply with the study protocol.

研究组 & 干预措施

cinnamon

Experimental

The test meal consisted of ½ cup dry instant oatmeal, prepared with 1 cup of 2% milk served with 6 g of ground cinnamon.

干预措施: cinnamon (Dietary Supplement)

control

No Intervention

The test meal consisted of ½ cup dry instant oatmeal, prepared with 1 cup of 2% milk served without 6 g of ground cinnamon

结局指标

主要结局

insulin

时间窗: Baseline to 180 minutes

postprandial insulin response

glucose

时间窗: Baseline to 180 minutes

postprandial glucose reponse

次要结局

  • glucagon(Baseline to 180 minutes)
  • lipids(Baseline to 180 minutes)
  • C-peptide(Baseline to 180 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhaoping Li

Principal Investigator

University of California, Los Angeles

研究点 (1)

Loading locations...

相似试验

Effect Cinnamon Spice on Postprandial Glucose and... | 临床试验